As biopharma pipelines expand into oligonucleotides, mRNA therapeutics, biosimilars, and advanced cell culture systems, analytical laboratories need workflows that deliver sensitivity, robustness, reproducibility, and regulatory confidence.
This eBook brings together practical insights on the LC-MS and analytical technologies shaping next-generation biopharma and omics research. Topics include low-flow and microflow LC-MS, mRNA impurity profiling, population-scale proteomics, AI-supported metabolomics, and evolving approaches to biosimilarity assessment. Download to explore how advanced analytical platforms can support stronger data quality, improved workflow efficiency, and more informed scientific decision-making.
What You'll Learn
- Low-flow micro-LC approaches for oligonucleotide characterization and high-quality sequencing data
- Best practices for micro-LC mRNA impurity profiling, including sensitivity, solvent reduction, and regulatory considerations
- How microflow LC-MS balances sensitivity, stability, robustness, and throughput
- Nanoparticle-enriched LC-MS/MS workflows for population-scale proteomics
- The role of advanced metabolomics, AI, and automation in serum-free media development
- How evolving FDA guidance is shifting biosimilar development toward analytical comparability and targeted PK studies
Together, these articles show how modern LC-MS workflows can help laboratories address complex analytical demands across biopharma, omics, and applied life science research.